The latest generation of gene sequencers is driving innovation in precision medicine, according to Nazneen Aziz, executive director of Kaiser Permanente Research Bank. “Genomics has become a critical tool for the diagnosis and treatment of many diseases,” Aziz said.
The latest generation of gene sequencers is driving innovation in precision medicine, according to Nazneen Aziz, executive director of Kaiser Permanente Research Bank. While the sector has come a long way, especially in the connecting of genomic data to electronic health records, Aziz believes that there is still much to be done, saying: "the interpretation of protein-coding parts of the genome is somewhat mature, but we still don't know how to interpret the parts that are in-between genes".